Betaseron

Betaseron is a medicine used to treat multiple sclerosis. It helps manage the symptoms of the disease. It's a type of interferon, a protein that helps your immune system fight off infections. This specific type, interferon beta-1b, is used for people with relapsing-remitting or chronic progressive multiple sclerosis.

Brand names:Extavia
Medication

What people taking Betaseron report

Every report comes from a Lived member, sent anonymously.

Have you tried Betaseron for MS (Multiple Sclerosis)?

NameHow it went

About Betaseron

What It's For

Betaseron is the brand name for interferon beta-1b, an injectable medicine for adults with relapsing forms of multiple sclerosis (MS). In MS, the immune system damages the protective coating around nerves in the brain and spinal cord, which can cause episodes of new or worsening symptoms called relapses. Betaseron is approved for three situations: clinically isolated syndrome (a first MS-like episode lasting at least 24 hours, with findings on an MRI (magnetic resonance imaging) scan that suggest MS may follow), relapsing-remitting MS, and secondary progressive MS that is still active with relapses or new inflammation. Betaseron is a disease-modifying therapy, meaning its aim is to reduce future relapses and new nerve damage rather than to relieve the symptoms someone already has. It was first approved in the US in 1993 and is one of the older MS treatments; today disease-modifying options also include pills and infusions. Extavia was another brand name for the same medicine. Betaseron is not the same as interferon beta-1a (Avonex, Rebif, Plegridy), which is a related but different product with its own dosing.

How It Works

Interferons are proteins the body makes to help regulate immune responses. Interferon beta-1b is a laboratory-made version of interferon beta that is thought to calm the immune activity that drives inflammation in MS. Exactly how it reduces MS activity is not known. What the trials show is the practical effect. In the main two-year study of relapsing-remitting MS, people taking Betaseron had about one-third fewer relapses than people taking a placebo, and their MRI scans showed fewer new or growing areas of inflammation. In people who had just had a first MS-like episode, 28% on Betaseron had a second attack within two years, compared with 45% on placebo. Its effect on long-term disability is less clear: in secondary progressive MS, one large trial found slower worsening of disability and another did not.

Dosage & Administration

Betaseron is injected under the skin (subcutaneously) every other day. It comes as a powder in a vial that is mixed with the supplied liquid just before use; mixed medicine that is not used right away should be refrigerated and used within three hours. Many people use the optional BETACONNECT autoinjector, which is available by prescription through the manufacturer's support program. Treatment starts at a quarter of the full dose and increases in steps over six weeks, which helps the body adjust to flu-like side effects. A trained health professional supervises the first injection and teaches the technique. Changing the injection site each time lowers the risk of skin damage. If a dose is missed, take it as soon as you remember, then take the next one about 48 hours later. Never inject on two days in a row. If you take an extra dose or inject on consecutive days, call your prescriber right away.

Side Effects

Flu-like symptoms (fever, chills, muscle aches and tiredness) are the most common side effect, affecting more than half of people in trials. They are usually worst in the first months and become much less common with time. Taking a pain and fever reliever such as acetaminophen or ibuprofen on injection days can help. Redness, swelling or tenderness at injection sites is also very common. Lower white blood cell counts and raised liver enzymes are often found on blood tests without causing symptoms. Some side effects need prompt attention. In about 4% of people in trials, the skin at an injection site broke down and died (necrosis), sometimes leaving a scar. Contact your care team before injecting again if you notice a break in the skin, blue-black discoloration, or swelling or fluid draining from a site. Depression and suicidal thoughts occur more often in people taking interferon beta; report new or worsening low mood or any thoughts of suicide right away. Also call promptly about yellowing of the skin or eyes or dark urine, which can signal liver injury, and about new or increasing shortness of breath or fatigue, which can rarely signal high blood pressure in the lungs, sometimes years into treatment. Serious allergic reactions are rare. Trouble breathing or swelling of the face, tongue or throat after an injection needs emergency care.

Interactions & Warnings

Betaseron should not be used by anyone who has had an allergic reaction to interferon beta or to human albumin or mannitol, two ingredients in the product. Because it can affect the liver, prescribers weigh it carefully alongside alcohol or other medicines that can harm the liver, so tell your care team about everything you take, including over-the-counter drugs and supplements. People with existing heart failure need closer monitoring, because interferon beta has been linked to worsening heart failure in some cases. Interferon beta can also rarely trigger other immune or blood problems, such as a lupus-like illness or damage to small blood vessels, which is one reason for regular blood tests. If you are pregnant or planning a pregnancy, discuss it with your prescriber. Studies of pregnancies exposed to interferon beta-1b have not generally shown an increase in major birth defects, though there are no controlled studies. There are no data on whether it passes into breast milk.

What to Expect

Betaseron does not make existing MS symptoms go away, and its benefit is mostly seen over months to years as fewer relapses and fewer new lesions on MRI. Flu-like symptoms and injection site reactions are typically most noticeable in the first three months and ease for many people after that. Monitoring is part of treatment. Blood counts and liver tests are usually checked at one, three and six months after starting, and then periodically. Your neurologist will also follow your relapses, examinations and MRI scans to judge whether the medicine is controlling the disease. Some people develop antibodies against interferon beta-1b; it is not known how much this affects safety or benefit. Treatment is usually long term. If relapses or new lesions continue, or side effects are hard to live with, switching to another disease-modifying therapy is a common next step. Do not change the dose or schedule on your own.

Questions to Ask Your Doctor

  1. 1.Why is Betaseron a good fit for my type of MS compared with newer pills or infusions?
  2. 2.How will we judge whether it is working, and how often will I have MRI scans and blood tests?
  3. 3.What is the best way to manage flu-like symptoms and injection site reactions during the first few months?
  4. 4.Would the autoinjector make injections easier for me, and who can help if I have trouble injecting?
  5. 5.How would Betaseron fit with my plans for pregnancy or breastfeeding?

Last reviewed • Oct 2026

Educational content, not medical advice.